Take a deeper dive

Webinar | Clinical Pharmacology 101: How to Form a Clinical Pharmacology Strategy for Your NDA/BLA

This webinar covers how to form a clinical pharmacology strategy for your drug development program. All drug programs must address clinical pharmacology to enable an approvable NDA or BLA. Understanding basic clinical pharmacology strategies such as which investigations you need or don’t need and which investigations to do now versus later is important for your program’s overall strategy.

At the end of this webinar attendees should have a better understanding of:

  • Approaches to designing a clinical pharmacology program
  • How to build a clinical pharmacology program
  • Common mistakes and lessons learned
  • Hypothetical examples of clinical pharmacology programs

Meet the Speaker

Geoffrey Banks, PhD
Chief Executive Officer

Dr. Banks founded Nuventra in 2008 and has led the company since then as both CEO and as a principal consultant. He has over 20 years of extensive experience in large pharma, biotechnology, and specialty pharma, and an established track record of clinical, regulatory, and entrepreneurial success. Dr. Banks has served as a clinical pharmacology consultant and corporate R&D advisor to over 300 companies that range from venture-backed startup biotech companies through large multinational pharmaceutical companies.

Explore Our Blog

When Should You Hire a Clinical Pharmacologist?

Because of the importance of clinical pharmacology to drug development, it is essential to consider the expertise of your product…

Read More

What Is CDISC and What Are CDISC Data Standards?

CDISC stands for the “Clinical Data Interchange Standards Consortium,” and is a global not-for-profit organization that actively develops data standards…

Read More

FDA Orphan Drug Designation for Rare Diseases

An estimated 30 million people in the United States are afflicted with rare (orphan) diseases or conditions; however, the availability…

Read More